| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1bde28565d28f037e78bf4a67776ee24 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18 |
| filingDate |
1998-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07a691965dbbf09af93f80a97787406e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7de096da3e6ed56ec31c64724e0083c1 |
| publicationDate |
2000-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CZ-477899-A3 |
| titleOfInvention |
5- (2-ethyl-2H-tetrazol-5-yl) -1-methyl-1,2,3,6-tetrahydropyridine maleate addition salt |
| abstract |
5- (2-Ethyl-2H-tetrazol-5-yl) -1-methyl-1-maleate-salt saltn2,3,6-tetrahydropyridine, pharmaceutical compositionsncontaining an acid addition salt and the use of such substancesnto treat disorders caused by poor functioningnacetylcholine (AcCH) or muscarinic system. |
| priorityDate |
1998-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |